ISRG

The Zacks Analyst Blog lists Intuitive Surgical (ISRG) among several tech and robotics stocks. It highlights the company as part of a broader robotics and AI theme.

Intuitive Surgical’s Ion platform is gaining traction, with more procedures, a larger installed base, and global expansion. This growth is positioning Ion as a second engine for the company.

Sands Capital, an investment management company, released its second-quarter 2026 investor letter for “Sands Capital Global Growth Fund”. The letter can be downloaded here. Global Growth seeks the best growth businesses worldwide, leveraging a research team that explores both developed and emerging markets for sustainable competitive advantages.

Report Features In-Depth Profiles of Abbott, Great Robotics, Intuitive Surgical, Johnson & Johnson, Medtronic, Panasonic, Renishaw, Siemens Healthineers, Smith+Nephew, Stryker, Zimmer Biomet, and FreehandDublin, Sept.

Intuitive Surgical’s growth has slowed from its post‑pandemic highs. The company now focuses on selling parts and services for existing robots rather than new robot sales.

A Yahoo article notes two stocks that have fallen 8% or more and suggests they may be attractive to investors.

Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried inside their business models quietly separates a compounder from a cyclical recovery story.

Robotics is entering a new era driven by AI, and four ETFs are highlighted as ways to invest in this sector.